Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, April 10, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, April 9, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Yuan Zhi Maintained (catx) at Strong Buy with Increased Target to $17 on, Apr 9th, 2024
Yuan Zhi of B. Riley Securities, Maintained "Perspective Therapeutics, Inc." (CATX) at Strong Buy with Increased Target from $12 to $17 on, Apr 9th, 2024.
Yuan has made no other calls on CATX in the last 4 months.
There is 1 other peer that has a rating on CATX. Out of the 1 peers that are also analyzing CATX, 0 agree with Yuan's Rating of Hold.
This is the rating of the analyst that currently disagrees with Yuan
- Jeff Jones of "Oppenheimer" Reiterated at Buy with Increased Target to $15 on, Monday, April 1st, 2024
